Arcadia Biosciences RKDA

$ 4.82 2.55%

Quarterly report 2024-Q3
added 11-12-2024

Arcadia Biosciences Balance Sheet 2011-2024 | RKDA

Annual Balance Sheet Arcadia Biosciences

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-5.51 M	-18.6 M	-25.4 M	-10.8 M	-8.29 M	-12 M	-9.12 M	71.7 M	27.2 M	-2.1 M	11.7 M	2.65 M	-
Long Term Debt	155 K	1.01 M	2.22 M	2.1 M	107 K	-	-	25.1 M	24.9 M	8.87 M	9.92 M	8 M	-
Long Term Debt Current	852 K	1.01 M	1.07 M	717 K	611 K	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	12.5 M	18.5 M	8.16 M	5.04 M	31.2 M	30.6 M	15.5 M	17.3 M	15.7 M	-
Total Current Liabilities	3.59 M	4.21 M	5.04 M	6.31 M	5.71 M	3.05 M	3.52 M	3.13 M	3.45 M	-	-	-	-
Total Liabilities	7 M	8.02 M	12.7 M	18.8 M	24.2 M	11.2 M	8.56 M	34.4 M	34 M	26.8 M	26.8 M	19 M	-
Deferred Revenue	-	-	-	8 K	42 K	96 K	1 M	740 K	1.01 M	830 K	1.07 M	1.16 M	-
Retained Earnings	-272 M	-258 M	-226 M	-212 M	-207 M	-178 M	-167 M	-152 M	-132 M	-114 M	-95.6 M	-82.4 M	-
Total Assets	19.7 M	28.9 M	43.9 M	47.3 M	32.6 M	24 M	16.6 M	56.6 M	74.2 M	24.9 M	9.54 M	13.4 M	-
Cash and Cash Equivalents	6.52 M	20.6 M	28.7 M	14 M	8.42 M	12 M	9.12 M	2.01 M	24 M	16.6 M	-	-	-
Book Value	12.7 M	20.9 M	31.2 M	28.6 M	8.33 M	12.8 M	8.01 M	22.2 M	40.2 M	-1.88 M	-17.3 M	-5.68 M	-
Total Shareholders Equity	12.8 M	21 M	31.1 M	27.7 M	7.7 M	12.8 M	8.01 M	22.2 M	40.2 M	-84.8 M	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Arcadia Biosciences

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	11 K	21 K	155 K	347 K	532 K	760 K	1.01 M	1.27 M	1.5 M	1.71 M	2.22 M	78 K	87 K	96 K	2.1 M	2.1 M	2.1 M	2.1 M	107 K	107 K	107 K	1.5 M	-	-	-	-	-	-	21.1 M	23.1 M	25.1 M	25.1 M	25.1 M	25.1 M	24.9 M	24.9 M	24.9 M	24.9 M	8.87 M	8.87 M	8.87 M	8.87 M	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26.7 M	26.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	5.09 M	5.8 M	5.56 M	7 M	8.07 M	9.07 M	13.7 M	8.02 M	9.46 M	8.24 M	8.56 M	12.7 M	19 M	28.1 M	25.1 M	18.8 M	18.8 M	18.8 M	18.8 M	24.2 M	24.2 M	24.2 M	24.2 M	11.2 M	11.2 M	11.2 M	11.2 M	8.56 M	8.56 M	8.56 M	8.56 M	34.4 M	34.4 M	34.4 M	34.4 M	34 M	34 M	34 M	34 M	26.8 M	26.8 M	26.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	63 K	63 K	8 K	8 K	8 K	8 K	42 K	42 K	42 K	42 K	96 K	316 K	470 K	571 K	1 M	626 K	1 M	1 M	740 K	740 K	740 K	740 K	1.01 M	1.01 M	1.01 M	1.01 M	830 K	830 K	830 K	830 K	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-275 M	-273 M	-274 M	-272 M	-269 M	-266 M	-267 M	-258 M	-254 M	-251 M	-247 M	-226 M	-217 M	-215 M	-210 M	-212 M	-212 M	-212 M	-212 M	-207 M	-207 M	-207 M	-207 M	-178 M	-178 M	-178 M	-178 M	-167 M	-167 M	-167 M	-167 M	-152 M	-152 M	-152 M	-152 M	-132 M	-132 M	-132 M	-132 M	-114 M	-114 M	-114 M	-114 M	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	15.2 M	17.4 M	16 M	19.7 M	23.5 M	26.8 M	30.4 M	28.9 M	34.5 M	35 M	38.8 M	43.9 M	59.2 M	70.8 M	70.8 M	47.3 M	47.3 M	47.3 M	47.3 M	32.6 M	32.6 M	32.6 M	32.6 M	24 M	24 M	24 M	24 M	16.6 M	16.6 M	16.6 M	16.6 M	56.6 M	56.6 M	56.6 M	56.6 M	74.2 M	74.2 M	74.2 M	74.2 M	24.9 M	24.9 M	24.9 M	24.9 M	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	3.94 M	5.5 M	3.32 M	6.52 M	10.6 M	13.5 M	23 M	20.6 M	22.7 M	21.2 M	24.6 M	28.7 M	35.5 M	44 M	32.8 M	14 M	14 M	14 M	14 M	8.42 M	8.42 M	8.42 M	8.42 M	12 M	12 M	12 M	12 M	9.12 M	9.12 M	9.12 M	9.12 M	2.01 M	2.01 M	2.01 M	2.01 M	24 M	24 M	24 M	24 M	16.6 M	16.6 M	16.6 M	16.6 M	2.84 M	-	-	-	-	-	-	-	-	-	-	-
Book Value	10.1 M	11.6 M	10.5 M	12.7 M	15.4 M	17.7 M	16.7 M	20.9 M	25 M	26.8 M	30.2 M	31.2 M	40.2 M	42.7 M	45.7 M	28.6 M	28.6 M	28.6 M	28.6 M	8.33 M	8.33 M	8.33 M	8.33 M	12.8 M	12.8 M	12.8 M	12.8 M	8.01 M	8.01 M	8.01 M	8.01 M	22.2 M	22.2 M	22.2 M	22.2 M	40.2 M	40.2 M	40.2 M	40.2 M	-1.88 M	-1.88 M	-1.88 M	24.9 M	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	10.3 M	11.7 M	10.6 M	12.8 M	15.4 M	17.7 M	16.7 M	21 M	25 M	26.8 M	30.2 M	31.1 M	40.2 M	42.7 M	45.7 M	27.7 M	27.7 M	27.7 M	27.7 M	7.7 M	7.7 M	7.7 M	7.7 M	12.8 M	12.8 M	12.8 M	12.8 M	8.01 M	8.01 M	8.01 M	8.01 M	22.2 M	22.2 M	22.2 M	22.2 M	40.2 M	40.2 M	40.2 M	40.2 M	-84.8 M	-84.8 M	-84.8 M	-84.8 M	-17.3 M	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency